Guilherme Dabus1,2,3, Jonathan A Grossberg4, C Michael Cawley4, Jacques E Dion4, Ajit S Puri5, Ajay K Wakhloo5, Douglas Gonsales6, Pedro Aguilar-Salinas6, Eric Sauvageau6, Italo Linfante1,2,3, Ricardo A Hanel6. 1. Miami Cardiac & Vascular Institute, Florida International University, Miami, Florida, USA. 2. Baptist Neuroscience Center, Florida International University, Miami, Florida, USA. 3. Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA. 4. Departments of Radiology and Neurosurgery, Emory University, Atlanta, Georgia, USA. 5. Department of Radiology, University of Massachusetts, Worcester, Massachusetts, USA. 6. Baptist Neurological Institute, Baptist Health System, Jacksonville, Florida, USA.
Abstract
BACKGROUND: The off-label use of flow diverters in the treatment of distal aneurysms continues to be debated. OBJECTIVE: To report our multicenter experience in the treatment of complex anterior cerebral artery aneurysms with the Pipeline embolization device (PED). METHODS: The neurointerventional databases of the four participating institutions were retrospectively reviewed for aneurysms treated with PED between October 2011 and January of 2016. All patients treated for anterior cerebral artery aneurysms were included in the analysis. Clinical presentation, location, type, vessel size, procedural complications, clinical and imaging follow-up were included in the analysis. RESULTS: Twenty patients (13 female) with 20 aneurysms met the inclusion criteria in our study. Fifteen aneurysms were classified as saccular and five as fusiform (mean size 7.3 mm). Thirteen aneurysms were located in the anterior communicating region (ACOM or A1/2 junction), six were A2-pericallosal, and one was located in the A1 segment. Six patients had presented previously with subarachnoid hemorrhage and had their aneurysms initially clipped or coiled. There was one minor event (a small caudate infarct) and one major event (intraparenchymal hemorrhage). Sixteen of the 20 patients had angiographic follow-up (mean 10 months). Eleven aneurysms were completely occluded, one had residual neck, and four had residual aneurysm filling. CONCLUSIONS: The treatment of complex anterior cerebral artery aneurysms with the PED as an alternative for patients who are not good candidates for conventional methods is technically feasible and safe. Mid-term results are promising but larger series with long-term follow-up are required to assess its effectiveness. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: The off-label use of flow diverters in the treatment of distal aneurysms continues to be debated. OBJECTIVE: To report our multicenter experience in the treatment of complex anterior cerebral artery aneurysms with the Pipeline embolization device (PED). METHODS: The neurointerventional databases of the four participating institutions were retrospectively reviewed for aneurysms treated with PED between October 2011 and January of 2016. All patients treated for anterior cerebral artery aneurysms were included in the analysis. Clinical presentation, location, type, vessel size, procedural complications, clinical and imaging follow-up were included in the analysis. RESULTS: Twenty patients (13 female) with 20 aneurysms met the inclusion criteria in our study. Fifteen aneurysms were classified as saccular and five as fusiform (mean size 7.3 mm). Thirteen aneurysms were located in the anterior communicating region (ACOM or A1/2 junction), six were A2-pericallosal, and one was located in the A1 segment. Six patients had presented previously with subarachnoid hemorrhage and had their aneurysms initially clipped or coiled. There was one minor event (a small caudate infarct) and one major event (intraparenchymal hemorrhage). Sixteen of the 20 patients had angiographic follow-up (mean 10 months). Eleven aneurysms were completely occluded, one had residual neck, and four had residual aneurysm filling. CONCLUSIONS: The treatment of complex anterior cerebral artery aneurysms with the PED as an alternative for patients who are not good candidates for conventional methods is technically feasible and safe. Mid-term results are promising but larger series with long-term follow-up are required to assess its effectiveness. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: J M Ospel; G Gascou; V Costalat; L Piergallini; K A Blackham; D W Zumofen Journal: AJNR Am J Neuroradiol Date: 2019-02-07 Impact factor: 3.825
Authors: Anna Luisa Kühn; Peter Kan; Nils Henninger; Visish Srinivasan; Katyucia de Macedo Rodrigues; Ajay K Wakhloo; Matthew J Gounis; Ajit S Puri Journal: J Clin Neurosci Date: 2019-05-06 Impact factor: 1.961
Authors: F Cagnazzo; P Perrini; C Dargazanli; P-H Lefevre; G Gascou; R Morganti; D di Carlo; I Derraz; C Riquelme; A Bonafe; V Costalat Journal: AJNR Am J Neuroradiol Date: 2019-03-14 Impact factor: 3.825
Authors: Sophia Hohenstatt; Sergio L Vinci; Dominik F Vollherbst; Agostino Tessitore; Niclas Schmitt; Antonio Pitrone; Antonio A Caragliano; Mariano Velo; Markus A Möhlenbruch; Aldo Paolucci Journal: Clin Neuroradiol Date: 2022-06-29 Impact factor: 3.649
Authors: F Diana; A Pesce; G Toccaceli; V Muralidharan; E Raz; M Miscusi; A Raco; P Missori; S Peschillo Journal: Neurosurg Rev Date: 2021-10-07 Impact factor: 3.042
Authors: David C Lauzier; Brandon K Root; Yasha Kayan; Josser E Delgado Almandoz; Joshua W Osbun; Arindam R Chatterjee; Kayla L Whaley; Megan E Tipps; Christopher J Moran; Akash P Kansagra Journal: Interv Neuroradiol Date: 2021-05-05 Impact factor: 1.610
Authors: Mehdi Abbasi; Luis E Savasatano; Waleed Brinjikji; Kevin M Kallmes; Nick Mikoff; Natalie Reierson; Mohamed Abdelmegeed; John Pederson; Beth Warren; Jillienne C Touchette; Sarah Khan; Shelby Kamrowski; Averi Barrett; David F Kallmes; Ramanathan Kadirvel Journal: Interv Neuroradiol Date: 2021-06-22 Impact factor: 1.764